Moderna prepares to release Phase 3 cancer-treatment results
Moderna is expected to reveal full Phase 3 data for its customized mRNA cancer treatment this weekend. The program applies the company’s mRNA technology, previously associated with its COVID-19 vaccine, to melanoma and potentially other cancers. MarketWatch…
